Belantamab (Anti-TNFRSF17 / BCMA / CD269)Belantamab (Anti-TNFRSF17 / BCMA / CD269)
Move your mouse over image or click to enlarge

Belantamab (Anti-TNFRSF17 / BCMA / CD269)

Belantamab (Anti-TNFRSF17 / BCMA / CD269) is a humanized monoclonal antibody directed against the B-cell maturation antigen (BCMA) that can be used in the synthesis of an antibody-drug conjugate (ADC), Belantamab mafodotin. MW : 145.5 KD.
Cat# Size Price Qty Buy
A2328-1mg*25 1mg*25
£2,432.00
A2328-1mg*5 1mg*5
£794.00
A2328-1mg 1mg
£303.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2328

Related Documents